SENATE DOCKET, NO. 2135        FILED ON: 2/19/2021

SENATE  .  .  .  .  .  .  .  .  .  .  .  .  .  .  No. 1139

 

The Commonwealth of Massachusetts

_________________

PRESENTED BY:

Bruce E. Tarr

_________________

To the Honorable Senate and House of Representatives of the Commonwealth of Massachusetts in General
Court assembled:

The undersigned legislators and/or citizens respectfully petition for the adoption of the accompanying bill:

An Act relative to involuntary holds for overdose treatment.

_______________

PETITION OF:

 

Name:

District/Address:

 

Bruce E. Tarr

First Essex and Middlesex

 

Steven G. Xiarhos

5th Barnstable

1/20/2022

Patrick M. O'Connor

Plymouth and Norfolk

1/20/2022

Walter F. Timilty

Norfolk, Bristol and Plymouth

1/25/2022

Carmine Lawrence Gentile

13th Middlesex

1/25/2022


SENATE DOCKET, NO. 2135        FILED ON: 2/19/2021

SENATE  .  .  .  .  .  .  .  .  .  .  .  .  .  .  No. 1139

By Mr. Tarr, a petition (accompanied by bill, Senate, No. 1139) of Bruce E. Tarr for legislation relative to involuntary holds for overdose treatment.  The Judiciary.

 

[SIMILAR MATTER FILED IN PREVIOUS SESSION
SEE SENATE, NO. 1035 OF 2019-2020.]

 

The Commonwealth of Massachusetts

 

_______________

In the One Hundred and Ninety-Second General Court
(2021-2022)

_______________

 

An Act relative to involuntary holds for overdose treatment.

 

Be it enacted by the Senate and House of Representatives in General Court assembled, and by the authority of the same, as follows:
 

Section 51 1/2 of chapter 111 of the General Laws, as inserted by section 32 of chapter 52 of the acts of 2016, is hereby amended by inserting after subsection (d) the following subsection:-

(d ½) A person presenting in an acute-care hospital or a satellite emergency facility who is reasonably believed by the treating clinician to be experiencing an opiate-related overdose, and who has experienced at least 1 other opiate-related overdose or potential overdose within a 30 day period, may be held, at the treating clinician’s discretion, for a period up to 72 hours for treatment, evaluation, and counseling.”.